1.0Cilcarehttps://www.cilcare.com/jprich600338<blockquote class="wp-embedded-content" data-secret="goGDcEdOJF"><a href="https://www.cilcare.com/jp/team/gautier-tejedor/">Gautier TEJEDOR</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.cilcare.com/jp/team/gautier-tejedor/embed/#?secret=goGDcEdOJF" width="600" height="338" title="“Gautier TEJEDOR” — Cilcare" data-secret="goGDcEdOJF" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://www.cilcare.com/wp-includes/js/wp-embed.min.js </script>https://www.cilcare.com/wp-content/uploads/2024/12/Gautier-Tejedor.jpg610763Gautier brings over 10 years of experience in academic research and start-up environment specializing in cell therapy and regenerative medicine. He developed deep expertise in inflammation, immunity, and advanced in vivo and in vitro models at CHU Montpellier. Gautier then transitioned to a biotech company, where he served as Project Manager and Purchasing Manager, playing a key role in developing and managing preclinical research projects. Known for his adaptability and agility, Gautier combines his strong background in project management and purchasing to ensure the successful execution of preclinical studies at Cilcare.